adjuvant
Showing 1 - 25 of >10,000
Recurrent Glioblastoma Trial in Brussels (Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV,
Not yet recruiting
- Recurrent Glioblastoma
- Neo-adjuvant nivolumab and ipililumab IV + adjuvant nivolumab and ipililumab IV
- +2 more
-
Brussels, BelgiumUZ Brussel
Oct 23, 2023
Adjuvant Radiotherapy and Combined Adjuvant Treatment Strategy
Recruiting
- Urothelial Carcinoma
- Radiotherapy
- +2 more
-
Beijing, China
- +2 more
Nov 2, 2023
Therapeutic Mammoplasty on the Start of Adjuvant Chemotherapy
Completed
- Effect of Therapeutic Mammoplasty on Adjuvant Chemotherapy
- therapeutic mammoplasty
- (no location specified)
Jun 16, 2023
Cancer Trial in Villejuif (Pembrolizumab, Pembrolizumab and Olaparib, Pembrolizumab adjuvant)
Not yet recruiting
- Cancer
- Pembrolizumab
- +2 more
-
Villejuif, Val De Marne, FranceGustave Roussy
Oct 30, 2023
Esophageal Cancer Trial (Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B), Adjuvant chemoradiotherapy)
Not yet recruiting
- Esophageal Cancer
- Adjuvant Immunoradiotherapy (ARM1) and Adjuvant Immunotherapy (ARM1B)
- Adjuvant chemoradiotherapy
- (no location specified)
Dec 19, 2022
Brain Metastases Trial (Gamma Tile-Surgically Targeted Radiation Therapy (STaRT), Stereotactic Radiation Therapy)
Not yet recruiting
- Brain Metastases
- Gamma Tile-Surgically Targeted Radiation Therapy (STaRT)
- Stereotactic Radiation Therapy
- (no location specified)
Jun 2, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Hepatocellular Carcinoma, Recurrence, Immune Checkpoint Inhibitor Trial in Nanning (Adjuvant tislelizumab plus lenvatinib,
Not yet recruiting
- Hepatocellular Carcinoma
- +2 more
- Adjuvant tislelizumab plus lenvatinib
- Adjuvant tislelizumab
-
Nanning, ChinaJian-Hong Zhong
Jun 11, 2023
Pancreatic Neuroendocrine Tumor G2 Trial (Octreotide LAR)
Completed
- Pancreatic Neuroendocrine Tumor G2
- Octreotide LAR
- (no location specified)
Oct 17, 2023
Uterine Cervical Tumors, Chemoradiotherapy, Adjuvant Chemo Trial in Liuzhou (paclitaxel combined with platinum)
Recruiting
- Uterine Cervical Neoplasms
- +2 more
- paclitaxel combined with platinum
-
Liuzhou, Guangxi, Chinathe Fourth Affiliated Hospital of Guangxi Medical University
Feb 16, 2023
Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia Trial (Nigella Sativa Oil capsule)
Not yet recruiting
- Nigella Sativa Oil as an Adjuvant Therapy in the Treatment of Pediatric Pneumonia
- Nigella Sativa Oil capsule
- (no location specified)
Jul 11, 2023
Relative Dose Intensity of Adjuvant Chemotherapy in Older ER+
Not yet recruiting
- Breast Cancer
- (no location specified)
Aug 21, 2023
to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally
Recruiting
- to Explore Whether the Adjuvant Therapy of Metronomic Capecitabine Could Improve the Disease-free Survival of Locoregionally Advanced Hypopharyngeal Carcinoma
- Capecitabine 500Mg Oral Tablet
-
Shanghai, ChinaEye & ENT Hospital, Fudan University
Jul 2, 2023
Stroke Trial in Tempe (START - Startle Adjuvant Rehabilitation Therapy, Sham Control)
Recruiting
- Stroke
- START - Startle Adjuvant Rehabilitation Therapy
- Sham Control
-
Tempe, ArizonaArizona State University
May 31, 2023
Bupivacaine, Dexamethasone, Magnesium Sulphate Trial in VAN (Bupivacaine + dexamethasone, Bupivacaine + magnesium sulphate,
Completed
- Bupivacaine
- +3 more
- Bupivacaine + dexamethasone
- +2 more
-
VAN, TurkeyHaci Yusuf GUNES
Oct 16, 2023
CT Imaging for Guiding PA-TACE for HCC
Recruiting
- Carcinoma, Hepatocellular
- postoperative adjuvant transarterial chemoembolization
-
Guangzhou, Guangdong, ChinaZhuJiang Hospital of Southern Medical University
Nov 30, 2023
Melanoma Stage III, In-Transit Metastasis of Cutaneous Melanoma Trial in Leiden (Encorafenib + Binimetinib)
Recruiting
- Melanoma Stage III
- In-Transit Metastasis of Cutaneous Melanoma
- Encorafenib + Binimetinib
-
Leiden, Zuid-Holland, NetherlandsLeiden University Medical Center
Mar 2, 2023
Metastatic Breast Cancer, Tumor, Muscle Tumors Trial in Colorado Springs (Method(s)1 Attribution, Method(s)2 Attribution,)
Not yet recruiting
- Metastatic Breast Cancer
- +3 more
- Method(s)1 Attribution
- Method(s)2 Attribution,
-
Colorado Springs, ColoradoPNAF Medical
Nov 23, 2023
Postoperative Pain Management, Postoperative Pain, Analgesia Trial in I?stanbul (Quadratus Lumborum Block III, Quadratus
Recruiting
- Postoperative Pain Management
- +5 more
- Quadratus Lumborum Block III
- Quadratus lumborum block III with Adjuvant
-
İ̇stanbul, Marmara, TurkeyGaziosmanpasa Research and Education Hospital
Aug 31, 2023
Radiotherapy, Breast Cancer, Relaxation Trial in Munich (Respiratory training and relaxation techniques under adjuvant radiation
Recruiting
- Radiotherapy
- +3 more
- Respiratory training and relaxation techniques under adjuvant radiation therapy in DIBH in breast cancer
-
Munich, GermanyDepartment of Radiation Oncology, Technical University of Munich
Aug 1, 2023
Recurrent Glioblastoma Trial in Houston (Pembrolizumab, Exablate MRgFUS + neoadjuvant pembolizumab)
Not yet recruiting
- Recurrent Glioblastoma
- Pembrolizumab
- Exablate MRgFUS + neoadjuvant pembolizumab
-
Houston, TexasM D Anderson Cancer Center
May 18, 2023